ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Larotaxel in Combination With Weekly Herceptin® in Patients With HER2 Positive Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00387907
Recruitment Status : Completed
First Posted : October 13, 2006
Last Update Posted : May 5, 2016
Sponsor:
Information provided by (Responsible Party):
Sanofi

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2008
  Actual Study Completion Date : March 2008
  Certification/Extension First Submitted : April 6, 2016